Ted Okerson

1.2k total citations
21 papers, 1.0k citations indexed

About

Ted Okerson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Ted Okerson has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Economics and Econometrics. Recurrent topics in Ted Okerson's work include Bariatric Surgery and Outcomes (9 papers), Diabetes Treatment and Management (8 papers) and Diabetes Management and Research (4 papers). Ted Okerson is often cited by papers focused on Bariatric Surgery and Outcomes (9 papers), Diabetes Treatment and Management (8 papers) and Diabetes Management and Research (4 papers). Ted Okerson collaborates with scholars based in United States, Ireland and Australia. Ted Okerson's co-authors include Leigh MacConell, Robert G. Brodows, John H. Holcombe, Prabhakar Viswanathan, Xuesong Guan, Ralph A. DeFronzo, Anthony H. Stonehouse, Anne M. Wolka, Donald K. Milton and Terry Ridge and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The American Journal of Cardiology.

In The Last Decade

Ted Okerson

21 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ted Okerson United States 11 845 479 364 255 89 21 1.0k
Matthew Wintle United States 12 1.4k 1.7× 582 1.2× 637 1.8× 308 1.2× 163 1.8× 18 1.6k
Fred Yang United States 9 771 0.9× 300 0.6× 386 1.1× 166 0.7× 50 0.6× 17 867
Marilyn K. Boardman United States 10 1.0k 1.2× 358 0.7× 470 1.3× 275 1.1× 84 0.9× 12 1.1k
Mario Widel United States 7 764 0.9× 281 0.6× 430 1.2× 139 0.5× 68 0.8× 11 922
Renee Amori United States 5 772 0.9× 296 0.6× 306 0.8× 157 0.6× 78 0.9× 7 893
Shizuka Kaneko Japan 11 847 1.0× 291 0.6× 400 1.1× 287 1.1× 188 2.1× 23 1.0k
Ken Wilhelm United States 6 874 1.0× 336 0.7× 371 1.0× 236 0.9× 75 0.8× 7 952
Julie Derving Karsbøl Denmark 9 1.1k 1.3× 277 0.6× 737 2.0× 290 1.1× 94 1.1× 15 1.2k
Charles Atisso United States 7 812 1.0× 253 0.5× 465 1.3× 244 1.0× 84 0.9× 18 864
Xiaosu Ma United States 10 451 0.5× 227 0.5× 169 0.5× 219 0.9× 132 1.5× 22 670

Countries citing papers authored by Ted Okerson

Since Specialization
Citations

This map shows the geographic impact of Ted Okerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Okerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Okerson more than expected).

Fields of papers citing papers by Ted Okerson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted Okerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Okerson. The network helps show where Ted Okerson may publish in the future.

Co-authorship network of co-authors of Ted Okerson

This figure shows the co-authorship network connecting the top 25 collaborators of Ted Okerson. A scholar is included among the top collaborators of Ted Okerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted Okerson. Ted Okerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rymer, Jennifer A., Katherine E. Mues, Keri L. Monda, et al.. (2020). Use of Low‐Density Lipoprotein–Lowering Therapies Before and After PCSK9 Inhibitor Initiation. Journal of the American Heart Association. 9(9). e014347–e014347. 17 indexed citations
2.
Chamberlain, Alanna M., Sarah S. Cohen, Jill M. Killian, et al.. (2019). Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease. The American Journal of Cardiology. 124(7). 995–1001. 10 indexed citations
3.
4.
Billy, Helmuth, David B. Sarwer, Jaime Ponce, et al.. (2014). Quality of Life After Laparoscopic Adjustable Gastric Banding (LAP-BAND): APEX Interim 3-Year Analysis. Postgraduate Medicine. 126(4). 131–140. 7 indexed citations
5.
Edelman, Steven V., Daisy Ng‐Mak, Mario Fusco, et al.. (2014). Control of type 2 diabetes after 1 year of laparoscopic adjustable gastric banding in the helping evaluate reduction in obesity (HERO) study. Diabetes Obesity and Metabolism. 16(10). 1009–1015. 11 indexed citations
6.
Dreyer, Nancy A, John B. Dixon, Ted Okerson, Eric Finkelstein, & Denise Globe. (2013). Prevalence of Comorbidities and Baseline Characteristics of LAP-BAND AP® Subjects in the Helping Evaluate Reduction in Obesity (HERO) Study. PLoS ONE. 8(11). e78971–e78971. 4 indexed citations
7.
Largent, Joan, Joseph Vasey, Leona Bessonova, Ted Okerson, & Nathan D. Wong. (2013). Reduction in Framingham Risk of Cardiovascular Disease in Obese Patients Undergoing Laparoscopic Adjustable Gastric Banding. Advances in Therapy. 30(7). 684–696. 8 indexed citations
8.
Ponce, Jaime, et al.. (2013). Efficacy and safety of the adjustable gastric band – pooled interim analysis of the APEX and HERO studies at 48 weeks. Current Medical Research and Opinion. 30(5). 841–848. 1 indexed citations
9.
James, Steven, et al.. (2013). Weight loss through adjustable gastric banding and improvement in daytime sleepiness: 2 year interim results of APEX study. Current Medical Research and Opinion. 30(5). 849–855. 2 indexed citations
10.
Woodman, George, et al.. (2012). Effect of adjustable gastric banding on changes in gastroesophageal reflux disease (GERD) and quality of life. Current Medical Research and Opinion. 28(4). 581–589. 39 indexed citations
11.
Edelman, Steven V., et al.. (2012). Effect of Early Weight Loss on Type 2 Diabetes Mellitus after 2 Years of Gastric Banding. Postgraduate Medicine. 124(6). 73–81. 3 indexed citations
12.
Largent, Joan, Michael G. Oefelein, Hilton M. Kaplan, Ted Okerson, & Peter Boyle. (2012). Risk of lymphoma in women with breast implants. European Journal of Cancer Prevention. 21(3). 274–280. 26 indexed citations
13.
Shayani, Vafa, et al.. (2012). Safety and Efficacy of the LAP-BAND AP® Adjustable Gastric Band in the Treatment of Obesity: Results at 2 Years. Postgraduate Medicine. 124(4). 181–188. 10 indexed citations
14.
Cywes, Robert, Sunil Bhoyrul, Helmuth Billy, et al.. (2011). Interim results at 48 weeks of LAP-BAND AP experience (APEX) study: prospective, multicenter, open-label longitudinal patient observational study. Surgery for Obesity and Related Diseases. 8(6). 741–746. 3 indexed citations
15.
Largent, Joan, et al.. (2011). Risk of lymphoma in women with breast implants: Analysis of clinical studies.. Journal of Clinical Oncology. 29(15_suppl). 1588–1588. 3 indexed citations
16.
Okerson, Ted, Peijing Yan, Anthony H. Stonehouse, & Robert G. Brodows. (2009). Effects of Exenatide on Systolic Blood Pressure in Subjects With Type 2 Diabetes. American Journal of Hypertension. 23(3). 334–339. 157 indexed citations
17.
Nielsen, Loretta L., Ted Okerson, John H. Holcombe, & Byron J. Hoogwerf. (2008). Effects of Exenatide on Diabetes, Obesity, Cardiovascular Risk Factors, and Hepatic Biomarkers in Patients with Type 2 Diabetes. Journal of Diabetes Science and Technology. 2(2). 255–260. 17 indexed citations
18.
Stonehouse, Anthony H., Ted Okerson, David M. Kendall, & David Maggs. (2008). Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors. Current Diabetes Reviews. 4(2). 101–109. 44 indexed citations
19.
Milton, Donald K., Terry Ridge, Leigh MacConell, et al.. (2008). Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study. Clinical Therapeutics. 30(8). 1448–1460. 309 indexed citations
20.
Kazda, Christof, Oliver Bachmann, Emily B. Button, et al.. (2008). Exenatide verbessert bei Patienten mit Typ-2-Diabetes die postprandiale Glucosekontrolle, gemessen an der Konzentration von 1,5-Anhydroglucitol. Diabetologie und Stoffwechsel. 3(S 1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew Wintle Breakdown of academic impact, for papers by Fred Yang Breakdown of academic impact, for papers by Marilyn K. Boardman Breakdown of academic impact, for papers by Mario Widel Breakdown of academic impact, for papers by Renee Amori Breakdown of academic impact, for papers by Shizuka Kaneko Breakdown of academic impact, for papers by Ken Wilhelm Breakdown of academic impact, for papers by Julie Derving Karsbøl Breakdown of academic impact, for papers by Charles Atisso Breakdown of academic impact, for papers by Xiaosu Ma
Rankless by CCL
2026